Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 72.8% in February

Ainos, Inc. (NASDAQ:AIMD) was the recipient of a significant drop in short interest in February. As of February 13th, there was short interest totaling 99,130 shares, a drop of 72.8% from the January 29th total of 364,031 shares. Currently, 2.3% of the company’s stock are short sold. Based on an average trading volume of 129,496 shares, the days-to-cover ratio is presently 0.8 days. Based on an average trading volume of 129,496 shares, the days-to-cover ratio is presently 0.8 days. Currently, 2.3% of the company’s stock are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Ainos in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Ainos Stock Performance

Shares of AIMD stock opened at $1.64 on Friday. The stock’s 50-day moving average price is $1.80 and its 200 day moving average price is $2.69. The company has a quick ratio of 2.67, a current ratio of 2.96 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $7.89 million, a PE ratio of -0.41 and a beta of 2.50. Ainos has a 52-week low of $1.26 and a 52-week high of $4.50.

Insider Transactions at Ainos

In other Ainos news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 28th. The shares were sold at an average price of $2.17, for a total transaction of $99,820.00. Following the completion of the transaction, the insider owned 989,925 shares in the company, valued at $2,148,137.25. The trade was a 4.44% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders have sold a total of 47,281 shares of company stock valued at $102,152 in the last ninety days. 9.79% of the stock is owned by insiders.

Institutional Investors Weigh In On Ainos

Several hedge funds have recently modified their holdings of the stock. Mariner LLC acquired a new position in Ainos in the 4th quarter valued at $37,000. DRW Securities LLC lifted its stake in shares of Ainos by 272.6% in the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after acquiring an additional 48,439 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Ainos by 13.1% in the fourth quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock valued at $109,000 after acquiring an additional 7,700 shares in the last quarter. Finally, Two Sigma Investments LP acquired a new position in shares of Ainos during the third quarter worth about $80,000.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.